Abstract
Rapid photometric assessment of iron in blood plasma and serum by a simple procedure after the extraction of iron(II) complex with 1-nitroso-2-naphthol in the micellar phase of a nonionic surfactant at the cloud point upon heating (pH range is 4.5–6.3) is proposed. The procedure trueness was verified using a standard reference protocol using bathophenanthroline. The advantages of the procedure are higher sensitivity than the reference protocol: the limit of detection is 0.03 μg/mL, the limit of quantitation is 0.1 μg/mL, the determination range is 0.1 – 2.8 μg/mL (RSD 0.02–0.10). Copper does not interfere with the iron assessment.
Keywords: iron assessment, plasma, serum, cloud-point extraction, spectrophotometry
Introduction
Iron level in blood plasma is affected by many physiological and pathological conditions 1. Plasma iron is determined in diagnosing hemochromatosis 2, 3, acute iron poisoning 4, active cirrhosis 5, or hepatitis 6, which lead to increased levels of transferrin, an iron(III)-binding glycoprotein that transports iron in the human body 7. Only 0.1% of the total iron is present in the blood plasma 2, thus its assessment should be rather sensitive, precise, and rapid.
Iron in plasma/serum is determined by spectrophotometry or atomic-absorption spectroscopy 8, 9 after the recovery of transferrin-bound iron(III) from acidic solutions using chelatants or detergents 10. Highly sensitive and specific though labour-extensive radioisotope 11 and immunological 12 assays for iron in blood plasma are seldom used due to the need for special equipment and expensive reagents. Spectrophotometric methods are most frequent in clinical practice and based on the formation of iron chelates with bathophenanthroline recommended as a reference method 13– 15 or its sulfonated analogue 14, 16, ferrozine 17, Ferene S 18– 20, or Chromazurol S 21. However, they are not always sensitive and (e.g. ferrozine) result in overestimation compared to bathophenanthroline 22.
We report rapid photometric determination of iron in blood plasma and serum by a simple procedure after the extraction of iron(II) complex with 1-nitroso-2-naphthol into the micellar phase of a nonionic surfactant at the cloud point upon heating.
Methods
An Agilent Cary 60 spectrophotometer (USA; optical path length, 1 cm) and an inoLab pH Level 1 pH-meter (Germany) with a glass pH-selective electrode (precision ±5%) were used. Solutions were mixed with a Biosan MMS 3000 automixer with a micro-stirrer. Mass-spectrometry measurements were performed on a quadrupole Agilent 7500c ICP-MS (Germany) in a time-resolved analysis mode. The sample introduction system consisted of a robust Babbington nebulizer with a Scott spray chamber (Agilent Technologies) cooled by a Peltier element (2°C). The data were acquired and processed with ICP-MS ChemStation (version G1834B) software (Agilent Technologies).
A GSO 7765-2000 Russian certified reference sample of Fe(III) (1.00 mg/mL in 0.1 M HCl) was used for calibration. 1-nitroso-2-naphthol (Reakhim, Russia) purified as in 23, ascorbic acid (Fluka, China), neonol (AF-neonol 9–12, Elarum, Russia), sodium and ammonium acetates, HCl, trichloroacetic acid (all from KhimMed, Russia), bathophenanthroline (ReaKhim, Russia), and ethanol (Ferien, Russia) were used.
Buffer solutions (pH 4) were prepared by adding the necessary amount of a 1M sodium acetate solution to 0.1 M hydrochloric acid. Chemically pure chloroform (KomponentReaktive, Russia) pre-washed with water from hydrochloric acid was used as a micellar phase diluent.
Blood samples were provided by 2 healthy volunteers. All tests were made in 3 replicates. To obtain native serum, a sample was put in a clean glass test tube and left for 1 h at room temperature to form a clot. The clot was separated from the walls with a glass tip and the sample was centrifuged for 15 min at 1500 rpm. The resulting serum was transferred into a clean test tube. For the decomposition of the iron(III) complex with transferrin, 0.5 ml of serum/plasma in a glass test tube was mixed with 1 ml of 2M HCl, next, 1 ml of fresh 2.5% ascorbic acid solution was added. The sample was diluted to 5 ml and mixed thoroughly.
Procedure with cloud-point extraction
A 1 ml portion of the test or a calibration solution is mixed with 1 ml of a 0.001M reagent solution in 5% neonol, 0.5 ml of 1M sodium acetate, and 8.5 ml of 5% neonol in a glass test tube. In the blank, 1 ml of distilled water was added instead of plasma/serum. Solutions were stirred in a boiling water bath for 15 min. Blood proteins denaturise and form a viscous white precipitate in the upper phase. Next, test tubes are cooled for 1 min in a cold-water stream, and the upper phase is removed by decanting. The lower, micellar, phase (0.6 mL) is diluted to 1.5 ml of chloroform and absorbance is measured at 715 nm against the blank.
Reference procedure with bathophenanthroline
0.7 ml of the test sample was mixed with 0.1 ml of 1% ascorbic acid, 0.35 ml of 1M HCl, and after stirring, with 0.2 ml of 20% trichloroacetic acid and centrifuged at 1500 rpm. A 0.7-ml supernatant of the reaction mixture is transferred into a test tube, 0.6 ml of saturated ammonium acetate and 0.7 ml of a bathophenanthroline solution in ethanol are added. After 1 min, absorbance is measured at 536 nm against the blank.
Results and discussion
The conditions for iron preconcentration with 1-nitroso-2-naphthol into a neonol micellar phase in the cloud point were selected as reported elsewhere 24. The iron recovery is 98 ± 2%. The optimum pH range is 4.5–6.3; the limit of detection is 0.03 µg/mL, the determination range is 0.1 – 2.8 µg/mL (RSD 0.02–0.10). The verification of the procedure using the reference protocol (bathophenanthroline) and an independent method (ICP-MS, isotope 54Fe) shows insignificantly different results ( Table 1).
Table 1. The results of extraction-photometric determination of iron(II) in biological fluids (concentration of 1-nitroso-2-naphthol, 1×10 -4 M, pH 4.8, t = 15 min, l = 1.0 cm, n = 3, P = 0.95).
| Sample | Blood plasma
(µg/mL) |
RSD | Blood serum
(µg/mL) |
RSD |
|---|---|---|---|---|
| CPE procedure | 1.71 ± 0.24 | 0.06 | 1.32 ± 0.17 | 0.05 |
| Reference method | 1.74 ± 0.16 a | 0.05 a | 1.34 ± 0.29 b | 0.09 b |
a ICP-MS
b Reference protocol with bathophenanthroline
The own colour of the reagent does not affect the blank. It is noteworthy that copper(II), existing in significant quantities in plasma and serum 25, does not interfere with the determination as the absorbance maximum of copper complex with nitroso-naphthols lies at 430–490 nm. This avoids using toxic and corrosive thioglycolic acid as a masking reagent. In addition, sample procedure provides the denaturisation of proteins and their removal at the stage of phase separation. Finally, the advantage of the proposed procedure over the bathophenanthroline protocol is much higher sensitivity: while the reference protocol assumes the determination at the boundary of the spectrophotometer working range, the results for our procedure correspond to its middle. Moreover, the separation does not exceed 15 min, which is promising for the development of rapid assessment protocols. It is also noteworthy that the extraction occurs under rather soft conditions, and the pH interval of complex formation in the nonionic surfactant is rather wide ( ca. 1 pH both in acidic and alkaline ranges).
http://dx.doi.org/10.5256/f1000research.6716.d100757
Blood samples were provided by 2 healthy volunteers. All tests were made in 3 replicates.
Copyright: © 2015 Samarina T and Proskurnin M
Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Data availability
The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2015 Samarina T and Proskurnin M
Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication). http://creativecommons.org/publicdomain/zero/1.0/
F1000Research: Dataset 1. Raw dataset for Samarina et al., 2015 'Rapid assessment of iron in blood plasma and serum by spectrophotometry with cloud-point extraction', 10.5256/f1000research.6716.d100757 26
Acknowledgements
We are grateful to Agilent Technologies — Russia and its CEO, Dr. Konstantin Evdokimov, for Agilent equipment used in this study. Samples of blood plasma courtesy of Dr. I. F. Seregina (M.V. Lomonosov Moscow State University).
Funding Statement
The work is supported by The Russian Science Foundation, grant no. 14-23-00012 (MP).
I confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
[version 1; referees: 2 approved]
References
- 1. Andrews NC: Iron metabolism: iron deficiency and iron overload. Annu Rev Genomics Hum Genet. 2000;1:75–98. 10.1146/annurev.genom.1.1.75 [DOI] [PubMed] [Google Scholar]
- 2. Hider RC, Kong X: Iron: effect of overload and deficiency. In: A. Sigel, H. Sigel, RKO. Sigel (Eds.) Interrelations between Essential. Interrelations between Essential Metal Ions and Human Diseases. Springer, Netherlands. 2013;13:229–294. 10.1007/978-94-007-7500-8_8 [DOI] [PubMed] [Google Scholar]
- 3. Kowdley KV: Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S79–S86. 10.1016/j.gastro.2004.09.019 [DOI] [PubMed] [Google Scholar]
- 4. Banner W, Jr, Tong TG: Iron poisoning. Pediatr Clin North Am. 1986;33(2):393–409. [DOI] [PubMed] [Google Scholar]
- 5. Stål P: Iron as a hepatotoxin. Dig Dis. 1995;13(4):205–222. [DOI] [PubMed] [Google Scholar]
- 6. Silva IS, Perez RM, Oliveira PV, et al. : Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study. J Gastroenterol Hepatol. 2005;20(2):243–248. 10.1111/j.1440-1746.2004.03549.x [DOI] [PubMed] [Google Scholar]
- 7. Wheby MS, Umpierre G: Effect of Transferrin Saturation on Iron Absorption in Man. N Engl J Med. 1964;271:1391–1395. 10.1056/NEJM196412312712704 [DOI] [PubMed] [Google Scholar]
- 8. Jittangprasert P, Wilairat P, Pootrakul P: Comparison of colorimetry and electrothermal atomic absorption spectroscopy for the quantification of non-transferrin bound iron in human sera. Southeast Asian J Trop Med Public Health. 2004;35(4):1039–1044. [PubMed] [Google Scholar]
- 9. Favier A, Maljournal B, Decoux G, et al. : Microanalysis of serum iron by atomatic absorption spectrophotometry in a graphite oven: improvement and evaluation of this method. Ann Biol Clin (Paris). 1983;41(1):45–50. [PubMed] [Google Scholar]
- 10. Koshiishi I, Mamura Y, Liu J, et al. : Evaluation of an acidic deproteinization for the measurement of ascorbate and dehydroascorbate in plasma samples. Clin Chem. 1998;44(4):863–868. [PubMed] [Google Scholar]
- 11. Fraser CG, Petersen PH, Ricos C, et al. : Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. Eur J Clin Chem Clin Biochem. 1992;30(5):311–317. 10.1515/cclm.1992.30.5.311 [DOI] [PubMed] [Google Scholar]
- 12. Levy AL, Vitacca P: Direct Determination and Binding Capacity of Serum Iron. Clin Chem. 1961;7(3):241–248. Reference Source [PubMed] [Google Scholar]
- 13. Lewis SM: International Committee for Standardization in Hematology: proposed recommendations for measurement of serum iron in human blood. Am J Clin Pathol. 1971;56(4):543–545. [DOI] [PubMed] [Google Scholar]
- 14. Recommendations for measurement of serum iron in human blood. Br J Haematol. 1978;38(2):291–294. 10.1111/j.1365-2141.1978.tb01045.x [DOI] [PubMed] [Google Scholar]
- 15. Derman DP, Green A, Bothwell TH, et al. : A systematic evaluation of bathophenanthroline, ferrozine and ferene in an ICSH-based method for the measurement of serum iron. Ann Clin Biochem. 1989;26(Pt 2):144–147. 10.1177/000456328902600209 [DOI] [PubMed] [Google Scholar]
- 16. Thomas B, Gautam A, Prasad BR, et al. : Evaluation of micronutrient (zinc, copper and iron) levels in periodontitis patients with and without diabetes mellitus type 2: a biochemical study. Indian J Dent Res. 2013;24(4):468–73. 10.4103/0970-9290.118400 [DOI] [PubMed] [Google Scholar]
- 17. Carter P: Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem. 1971;40(2):450–458. 10.1016/0003-2697(71)90405-2 [DOI] [PubMed] [Google Scholar]
- 18. Pieroni L, Khalil L, Charlotte F, et al. : Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration. Clin Chem. 2001;47(11):2059–2061. [PubMed] [Google Scholar]
- 19. Revised recommendations for the measurements of the serum iron in human blood. Iron Panel of the International Committee for Standardization in Haematology. Br J Haematol. 1990;75(4):615–616. 10.1111/j.1365-2141.1990.tb07808.x [DOI] [PubMed] [Google Scholar]
- 20. Charlier C, Plomteux G, Vernet M, et al. : Modification of the selected method for the determination of serum iron. Substitution of bathophenanthroline by ferene S. Ann Biol Clin (Paris). 1992;50(3):191–202. [PubMed] [Google Scholar]
- 21. Brivio G, Brega A, Torelli G: Determination of iron and iron-binding capacity in serum without blank sample. Ric Clin Lab. 1986;16(4):523–532. [DOI] [PubMed] [Google Scholar]
- 22. Lauber K: Determination of serum iron; a comparison of two methods: Teepol/dithionite/bathophenanthroline versus guanidine/ascorbic acid/Ferrozine (author's transl). J Clin Chem Clin Biochem. 1980;18(2):147–148. [PubMed] [Google Scholar]
- 23. Umland F, Janssen A, Thierig D, et al. : Theorie und pratische anwendung von komplexbildnern. Akademische Verlagsgesellschaft Frankfurt am Main. 1971. Reference Source [Google Scholar]
- 24. Samarina TO, Ivanov VM, Figurovskaya VN: Optical and chromaticity parameters of transition metal complexes with 1-nitroso-2-naphthol-3,6-disulfonic acid in the presence of surfactants. J Anal Chem (Russ.). 2012;67(4):321–329. 10.1134/S1061934812040053 [DOI] [Google Scholar]
- 25. Yamashita S, Abe A, Noma A: Sensitive, direct procedures for simultaneous determinations of iron and copper in serum, with use of 2-(5-nitro-2-pyridylazo)-5-(N-propyl-N-sulfopropylamino)phenol (nitro-PAPS) as ligand. Clin Chem. 1992;38(7):1373–1375. [PubMed] [Google Scholar]
- 26. Samarina T, Proskurnin M: Dataset 1 in: Rapid assessment of iron in blood plasma and serum by spectrophotometry with cloud-point extraction. F1000Research. 2015. Data Source [DOI] [PMC free article] [PubMed] [Google Scholar]